Jichun Yang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jichun Yang has a total of 83 co-authors. Here are the top co-authors by number of shared publications:
- Yang Luo
Kunming Medical University
13 shared publications Xiaohui Chen
11 shared publicationsXin Cui
8 shared publicationsYao Luo
8 shared publicationsHengyi Chen
Center of Smart Laboratory and Molecular Medicine, School of Medicine, Chongqing University, Chongqing, 400044, PR China
7 shared publicationsQianqian Wu
7 shared publications
Latest Publications
- 3 November 2026
- Published by Elsevier in Biomaterials
- Vol. 339
Energy band tunable piezoelectric nanozyme heterojunction toward cancer synergistic catalytic therapy
- 3 November 2026
- Published by Elsevier in Biomaterials
- Vol. 339
Energy band tunable piezoelectric nanozyme heterojunction toward cancer synergistic catalytic therapy
- Open Access
- 10 September 2026
- Published by Elsevier in SSRN Electronic Journal
Energy band tunable piezoelectric nanozyme heterojunction toward cancer synergistic catalytic therapy
Piezoelectric catalytic therapy (PCT) based on piezoelectric semiconductors provides a new approach for cancer therapy. Various researches have explored the construction of heterojunction structures with nanozymes to strengthen PCT effect via accelerating electron transfer kinetics and synergistic nanozyme catalysis therapy (NCT). However, limited by the fixed energy band structure of nanozymes, the selectable piezoelectric semiconductors and nanozymes with matched energy levels are few. In this work, Cu2+ engineered nanozyme MIL-100 (Fe) was self-assembled on the surface of piezoelectric material BaTiO3 (BTO) to obtain BaTiO3@MIL-100 (Fe, Cu) (BTO@Fe-Cu) nanoparticles (NPs) with flexible heterojunction types, which presented synergetic NCT and PCT effect. Theoretical calculations revealed that Cu2+ introduced a new 3d orbital in the Fe-O structure, which altered the charge transfer pathways and enhanced the dual-enzyme activity of MIL-100 (Fe). Lattice distortion further modulated the valence band gap and transformed the heterostructure from type-Ⅰ to type-S for high electron-hole separation efficiency. BTO@Fe-Cu NPs fundamentally intensified the efficiency of NCT and PCT, which synergistically activated the ferroptosis/cuproptosis pathways. Moreover, scRNA-seq analysis demonstrated that the piezoelectric nanozyme also remodeled the composition and evolutionary dynamics of immune cells. This effectively reversed the immunosuppressive tumor microenvironment (TME) and elicited robust immune activation for cancer immunotherapy.
- 10 September 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessEnergy band tunable piezoelectric nanozyme heterojunction toward cancer synergistic catalytic therapy
Piezoelectric catalytic therapy (PCT) based on piezoelectric semiconductors provides a new approach for cancer therapy. Various researches have explored the construction of heterojunction structures with nanozymes to strengthen PCT effect via accelerating electron transfer kinetics and synergistic nanozyme catalysis therapy (NCT). However, limited by the fixed energy band structure of nanozymes, the selectable piezoelectric semiconductors and nanozymes with matched energy levels are few. In this work, Cu2+ engineered nanozyme MIL-100 (Fe) was self-assembled on the surface of piezoelectric material BaTiO3 (BTO) to obtain BaTiO3@MIL-100 (Fe, Cu) (BTO@Fe-Cu) nanoparticles (NPs) with flexible heterojunction types, which presented synergetic NCT and PCT effect. Theoretical calculations revealed that Cu2+ introduced a new 3d orbital in the Fe-O structure, which altered the charge transfer pathways and enhanced the dual-enzyme activity of MIL-100 (Fe). Lattice distortion further modulated the valence band gap and transformed the heterostructure from type-Ⅰ to type-S for high electron-hole separation efficiency. BTO@Fe-Cu NPs fundamentally intensified the efficiency of NCT and PCT, which synergistically activated the ferroptosis/cuproptosis pathways. Moreover, scRNA-seq analysis demonstrated that the piezoelectric nanozyme also remodeled the composition and evolutionary dynamics of immune cells. This effectively reversed the immunosuppressive tumor microenvironment (TME) and elicited robust immune activation for cancer immunotherapy.
- 19 June 2026
- Published by Elsevier in Science Bulletin
- Vol. 71 (15) , 3853-3857
Highly reliable LFIA assay reveals long-term real-world dynamics of neutralizing antibodies against SARS-CoV-2
- 19 June 2026
- Published by Elsevier in Science Bulletin
- Vol. 71 (15) , 3853-3857
Highly reliable LFIA assay reveals long-term real-world dynamics of neutralizing antibodies against SARS-CoV-2
- Open Access
- 11 June 2026
- Published by Wiley in Advanced Healthcare Materials
- Vol. 15 (27) , e71350
A Photosensitizer‐Intercalated Programmable DNA System for Enhanced Photoimmunotherapy via Tumor Microenvironment Remodeling
Photoimmunotherapy (PIT) has emerged as a minimally invasive therapeutic modality for cancer, offering high spatial precision and favorable therapeutic outcomes. However, the aggregation‐caused quenching (ACQ) of photosensitizers and the hypoxic tumor microenvironment (TME) limit its overall efficacy. Herein, a DNA tetrahedron‐based nanoplatform (HPTM) functionalized with hypoxia‐inducible factor‐1α antisense oligonucleotide (HIF‐1α ASO) and PD‐L1 aptamers was engineered to load TMPyP for enhanced tumor PIT. The intercalation of TMPyP within the DNA framework effectively prevented photosensitizer aggregation, thus improving reactive oxygen species (ROS) production and photodynamic therapy (PDT) efficacy. Furthermore, the aptamer‐functionalized structure facilitated tumor targeting and blocked the PD‐1/PD‐L1 immune checkpoint on the cell surface. Concurrently, the intracellular delivery of HIF‐1α ASO downregulated endogenous PD‐L1 expression by disrupting the HIF‐1α/PD‐L1 signaling axis. This collaborative endogenous and exogenous strategy effectively remodeled the immunosuppressive TME. The downregulation of HIF‐1α also alleviated the hypoxic microenvironment, further supporting PDT performance. Upon irradiation, HPTM triggered immune activation via PDT‐induced immunogenic cell death (ICD) and promoted long‐term immunological memory. Overall, this multifunctional DNA‐programmed nanoplatform provides efficient photosensitizer loading and addresses the immune imbalance associated with PDT, offering a promising strategy for cancer PIT.
- 11 June 2026
- Published by Wiley in Advanced Healthcare Materials
- Vol. 15 (27) , e71350
Open AccessA Photosensitizer‐Intercalated Programmable DNA System for Enhanced Photoimmunotherapy via Tumor Microenvironment Remodeling
Photoimmunotherapy (PIT) has emerged as a minimally invasive therapeutic modality for cancer, offering high spatial precision and favorable therapeutic outcomes. However, the aggregation‐caused quenching (ACQ) of photosensitizers and the hypoxic tumor microenvironment (TME) limit its overall efficacy. Herein, a DNA tetrahedron‐based nanoplatform (HPTM) functionalized with hypoxia‐inducible factor‐1α antisense oligonucleotide (HIF‐1α ASO) and PD‐L1 aptamers was engineered to load TMPyP for enhanced tumor PIT. The intercalation of TMPyP within the DNA framework effectively prevented photosensitizer aggregation, thus improving reactive oxygen species (ROS) production and photodynamic therapy (PDT) efficacy. Furthermore, the aptamer‐functionalized structure facilitated tumor targeting and blocked the PD‐1/PD‐L1 immune checkpoint on the cell surface. Concurrently, the intracellular delivery of HIF‐1α ASO downregulated endogenous PD‐L1 expression by disrupting the HIF‐1α/PD‐L1 signaling axis. This collaborative endogenous and exogenous strategy effectively remodeled the immunosuppressive TME. The downregulation of HIF‐1α also alleviated the hypoxic microenvironment, further supporting PDT performance. Upon irradiation, HPTM triggered immune activation via PDT‐induced immunogenic cell death (ICD) and promoted long‐term immunological memory. Overall, this multifunctional DNA‐programmed nanoplatform provides efficient photosensitizer loading and addresses the immune imbalance associated with PDT, offering a promising strategy for cancer PIT.
- 5 March 2026
- Published by Royal Society of Chemistry (RSC) in The Analyst
- Vol. 151 (8) , 2166-2176
Self-protected circular DNAzyme for integrated enrichment and quantification of small extracellular vesicles
Small extracellular vesicles (sEVs) hold immense potential for liquid biopsy given the wealth of biological information they carry. Currently, the clinical application of these methods is limited due to their low abundance and the complexities associated with traditional isolation techniques. To address this, we developed a strategy integrating cholesterol-mediated capture with a Self-Protected DNAzyme Walker for the rapid and simultaneous specific isolation and quantification of small extracellular vesicles (sEVs). Upon specific binding to CD63, the blocker strand is released, which activates the DNAzyme catalytic core, leading to substrate cleavage, which triggers the specific release of sEVs from magnetic beads and the generation of a fluorescent signal. Importantly, the circular DNA Shield design provides remarkable stability to the system by safeguarding the DNAzyme core from nuclease degradation. Furthermore, the cyclic cleavage mechanism allows for highly sensitive detection, achieving a limit of detection (LOD) as low as 361 particles per μL. In addition, by leveraging the lipid bilayer structure for sEV enrichment, this strategy effectively eliminates interference from free proteins. Furthermore, the clinical feasibility of this assay was validated by successfully distinguishing Stage I breast cancer patients from healthy individuals with high statistical significance (p < 0.001), highlighting its promise for early cancer diagnosis. This work presents a robust paradigm for sEV analysis and lays a solid foundation for their downstream biomedical applications.
- 5 March 2026
- Published by Royal Society of Chemistry (RSC) in The Analyst
- Vol. 151 (8) , 2166-2176
Self-protected circular DNAzyme for integrated enrichment and quantification of small extracellular vesicles
Small extracellular vesicles (sEVs) hold immense potential for liquid biopsy given the wealth of biological information they carry. Currently, the clinical application of these methods is limited due to their low abundance and the complexities associated with traditional isolation techniques. To address this, we developed a strategy integrating cholesterol-mediated capture with a Self-Protected DNAzyme Walker for the rapid and simultaneous specific isolation and quantification of small extracellular vesicles (sEVs). Upon specific binding to CD63, the blocker strand is released, which activates the DNAzyme catalytic core, leading to substrate cleavage, which triggers the specific release of sEVs from magnetic beads and the generation of a fluorescent signal. Importantly, the circular DNA Shield design provides remarkable stability to the system by safeguarding the DNAzyme core from nuclease degradation. Furthermore, the cyclic cleavage mechanism allows for highly sensitive detection, achieving a limit of detection (LOD) as low as 361 particles per μL. In addition, by leveraging the lipid bilayer structure for sEV enrichment, this strategy effectively eliminates interference from free proteins. Furthermore, the clinical feasibility of this assay was validated by successfully distinguishing Stage I breast cancer patients from healthy individuals with high statistical significance (p < 0.001), highlighting its promise for early cancer diagnosis. This work presents a robust paradigm for sEV analysis and lays a solid foundation for their downstream biomedical applications.
- Open Access
- 1 February 2026
- Published by KEAI Publishing in Bioactive Materials
- Vol. 56, 666-681
Turmeric extracellular vesicles-derived “all-in-one” nanoagent enables full-cycle synergistic immunomodulation of lung cancer
Lung cancer's metastatic propensity and recurrence prevalence necessitate innovative immunotherapy strategies beyond conventional single-mode regulation. We engineered low-capacity turmeric-derived extracellular vesicles (TEVs) that integrated with zeolitic imidazolate framework-8 (ZIF-8) to construct an “all-in-one” nanoagent, addressing both high drug loading nanocarriers production and immunologically cold tumor challenges. The system co-delivered chlorin e6 (Ce6) and PD-L1 siRNA, while exploited TEVs' inherent curcumin for Wnt/β-catenin pathway inhibition. Ce6-mediated photodynamic therapy (PDT) induced immunogenic cell death (ICD), releasing damage associated molecular patterns (DAMPs) to activate antigen-presenting cells (APCs). Compared with control groups, artificial intelligence model confirmed the role of curcumin in enhancing immune infiltration by 6.1-fold. PD-L1 siRNA synergistically downregulates the checkpoint expression with a 66 % reduction in vivo to prevent the immune escape. This coordinated strategy achieved full-cycle immunomodulation: (1) ICD initiated antigens release, (2) Wnt/β-catenin pathway inhibition drived T cell infiltration, and (3) PD-L1 blockade receded the immune escape. In vivo results demonstrated that 64 % primary tumor suppression and 81 % metastasis reduction versus monotherapy groups. The ZIF-8@TEV hybrid platform exhibited 12.8 % payload loading efficiency, surpassing liposomal carriers by 4.7-fold. This study established a scalable nanoengineering approach to transform immunosuppressive tumors into immunotherapy-responsive targets through a full-cycle immune coordination.
- 1 February 2026
- Published by KEAI Publishing in Bioactive Materials
- Vol. 56, 666-681
Open AccessTurmeric extracellular vesicles-derived “all-in-one” nanoagent enables full-cycle synergistic immunomodulation of lung cancer
Lung cancer's metastatic propensity and recurrence prevalence necessitate innovative immunotherapy strategies beyond conventional single-mode regulation. We engineered low-capacity turmeric-derived extracellular vesicles (TEVs) that integrated with zeolitic imidazolate framework-8 (ZIF-8) to construct an “all-in-one” nanoagent, addressing both high drug loading nanocarriers production and immunologically cold tumor challenges. The system co-delivered chlorin e6 (Ce6) and PD-L1 siRNA, while exploited TEVs' inherent curcumin for Wnt/β-catenin pathway inhibition. Ce6-mediated photodynamic therapy (PDT) induced immunogenic cell death (ICD), releasing damage associated molecular patterns (DAMPs) to activate antigen-presenting cells (APCs). Compared with control groups, artificial intelligence model confirmed the role of curcumin in enhancing immune infiltration by 6.1-fold. PD-L1 siRNA synergistically downregulates the checkpoint expression with a 66 % reduction in vivo to prevent the immune escape. This coordinated strategy achieved full-cycle immunomodulation: (1) ICD initiated antigens release, (2) Wnt/β-catenin pathway inhibition drived T cell infiltration, and (3) PD-L1 blockade receded the immune escape. In vivo results demonstrated that 64 % primary tumor suppression and 81 % metastasis reduction versus monotherapy groups. The ZIF-8@TEV hybrid platform exhibited 12.8 % payload loading efficiency, surpassing liposomal carriers by 4.7-fold. This study established a scalable nanoengineering approach to transform immunosuppressive tumors into immunotherapy-responsive targets through a full-cycle immune coordination.
- 22 November 2025
- Published by Elsevier in Biomaterials
- Vol. 328, 123868
Well-defined electronic configuration cyano-bridged bimetallic nanozyme for cancer catalytic-immunotherapy
- 22 November 2025
- Published by Elsevier in Biomaterials
- Vol. 328, 123868
Well-defined electronic configuration cyano-bridged bimetallic nanozyme for cancer catalytic-immunotherapy
- Open Access
- 17 September 2025
- Published by Springer Nature in Light: Science & Applications
- Vol. 14 (1) , 1-10
Laser-emission vibrational microscopy of microdroplet arrays for high-throughput screening of hyperlipidemia
The mechanical properties of biological fluids serve as early indicators of disease, offering valuable insights into complex physiological and pathological processes. However, the existing technologies struggle to achieve high-throughput measurement, limiting their widespread applications in disease diagnosis. Here, we propose laser-emission vibrational microscopy of microdroplets for high-throughput measurement of the intrinsic mechanical properties of fluids. The microdroplet array supporting high Q-factor (104) whispering gallery modes (WGM) lasing was massively fabricated on a superhydrophobic surface with inkjet printing. Ultrasound was employed to actuate the mechanical vibrations of the microdroplets, and the vibration amplitude was quantified using time-resolved laser spectra. We found that the stimulus-response of the laser emission is strongly dependent on the liquid viscosity. Fast mapping of the microdroplets’ viscosities was achieved by stage scanning. High-throughput screening of hyperlipidemia disease was also demonstrated by performing over 2000 measurements within 25 min. Thanks to the small volume of the microdroplets, a single drop of blood can support over seven million measurements. The high-throughput ability and small sample consumption make it a promising tool for clinical diagnoses based on mechanical properties.
- 17 September 2025
- Published by Springer Nature in Light: Science & Applications
- Vol. 14 (1) , 1-10
Open AccessLaser-emission vibrational microscopy of microdroplet arrays for high-throughput screening of hyperlipidemia
The mechanical properties of biological fluids serve as early indicators of disease, offering valuable insights into complex physiological and pathological processes. However, the existing technologies struggle to achieve high-throughput measurement, limiting their widespread applications in disease diagnosis. Here, we propose laser-emission vibrational microscopy of microdroplets for high-throughput measurement of the intrinsic mechanical properties of fluids. The microdroplet array supporting high Q-factor (104) whispering gallery modes (WGM) lasing was massively fabricated on a superhydrophobic surface with inkjet printing. Ultrasound was employed to actuate the mechanical vibrations of the microdroplets, and the vibration amplitude was quantified using time-resolved laser spectra. We found that the stimulus-response of the laser emission is strongly dependent on the liquid viscosity. Fast mapping of the microdroplets’ viscosities was achieved by stage scanning. High-throughput screening of hyperlipidemia disease was also demonstrated by performing over 2000 measurements within 25 min. Thanks to the small volume of the microdroplets, a single drop of blood can support over seven million measurements. The high-throughput ability and small sample consumption make it a promising tool for clinical diagnoses based on mechanical properties.
- 15 August 2025
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 19 (34) , 31183-31200
A Spatiotemporally Controllable DNA Hydrogel Mesh for Focused Antimetastasis Therapy of Cancer
Cancer is one of the most commonly diagnosed diseases with high mortality, and approximately 50% of patients are prone to present metastasis after various treatments. The shedding of circulating tumor cells (CTCs) during tumor therapy is the root cause of metastasis. In this work, we proposed a focused antimetastasis therapy strategy based on a spatiotemporally controllable DNA hydrogel mesh (SNARE: just like a turtle trapped in the jar) in vivo. The whole treatment process was performed in the limited space of the SNARE, which realized the immobilization of CTCs in situ for antimetastasis effects. A stimulus-responsive reversible drug nanocarrier module and an epithelial cell adhesion molecule (EpCAM) aptamer recognition module endowed the SNARE with spatiotemporal controllability for precise tumor cell immobilization. The SNARE also activated a robust immune performance through overcoming immune escape, inducing immunogenic cell death, and enhancing the cGAS-STING pathway to assist the CTC immobilization strategy for a better antimetastasis efficiency. Moreover, it was found that the EpCAM aptamer could realize the endogenous PD-L1 regulation through the epidermal growth factor receptor pathway, and the immunotherapy efficiency was further intensified by the ordered networks of the DNA hydrogel. This work provided a focused antimetastasis therapy strategy for cancer through the immobilization of CTCs in a limited space, which also gave insight into alternative development approaches of immune checkpoint inhibitors.
- 15 August 2025
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 19 (34) , 31183-31200
A Spatiotemporally Controllable DNA Hydrogel Mesh for Focused Antimetastasis Therapy of Cancer
Cancer is one of the most commonly diagnosed diseases with high mortality, and approximately 50% of patients are prone to present metastasis after various treatments. The shedding of circulating tumor cells (CTCs) during tumor therapy is the root cause of metastasis. In this work, we proposed a focused antimetastasis therapy strategy based on a spatiotemporally controllable DNA hydrogel mesh (SNARE: just like a turtle trapped in the jar) in vivo. The whole treatment process was performed in the limited space of the SNARE, which realized the immobilization of CTCs in situ for antimetastasis effects. A stimulus-responsive reversible drug nanocarrier module and an epithelial cell adhesion molecule (EpCAM) aptamer recognition module endowed the SNARE with spatiotemporal controllability for precise tumor cell immobilization. The SNARE also activated a robust immune performance through overcoming immune escape, inducing immunogenic cell death, and enhancing the cGAS-STING pathway to assist the CTC immobilization strategy for a better antimetastasis efficiency. Moreover, it was found that the EpCAM aptamer could realize the endogenous PD-L1 regulation through the epidermal growth factor receptor pathway, and the immunotherapy efficiency was further intensified by the ordered networks of the DNA hydrogel. This work provided a focused antimetastasis therapy strategy for cancer through the immobilization of CTCs in a limited space, which also gave insight into alternative development approaches of immune checkpoint inhibitors.
- 6 June 2025
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 97 (25) , 13325-13334
Precise Determination of CpG Methylation through Entropy-Driven Cascade Circuit
Aberrant methylation of a particular region plays a crucial role in the occurrence and development of malignant tumors. However, the sensitive and precise determination of DNA methylation from clinical samples remains challenging. Here, we developed a sensitive and specific approach for determining methylation with multiple isothermal amplification cascade quantum dot signal output. To increase the sensitivity, an entropy-driven circuit was exploited to specifically recognize the single P16 promoter methylation site and trigger the first amplification, whose product could initiate a hybridization chain reaction for the second amplification. Then, G-quadruplex-rich DNA polymer nanowires were self-assembled, which could bind with quantum dot-labeled TMPyP to turn on the fluorescence, realizing a reliable signal output of trace target. Finally, the proposed approach demonstrated a detection limit of 358.92 aM for the P16 promotor methylation concentration ranging from 1 fM to 1 nM within 1.5 h. In summary, this study provides a sensitive and rapid approach for the determination of methylation via isothermal amplification coupled with quantum dot labeling, paving a new strategy for the early diagnosis and monitoring of cancer development.
- 6 June 2025
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 97 (25) , 13325-13334
Precise Determination of CpG Methylation through Entropy-Driven Cascade Circuit
Aberrant methylation of a particular region plays a crucial role in the occurrence and development of malignant tumors. However, the sensitive and precise determination of DNA methylation from clinical samples remains challenging. Here, we developed a sensitive and specific approach for determining methylation with multiple isothermal amplification cascade quantum dot signal output. To increase the sensitivity, an entropy-driven circuit was exploited to specifically recognize the single P16 promoter methylation site and trigger the first amplification, whose product could initiate a hybridization chain reaction for the second amplification. Then, G-quadruplex-rich DNA polymer nanowires were self-assembled, which could bind with quantum dot-labeled TMPyP to turn on the fluorescence, realizing a reliable signal output of trace target. Finally, the proposed approach demonstrated a detection limit of 358.92 aM for the P16 promotor methylation concentration ranging from 1 fM to 1 nM within 1.5 h. In summary, this study provides a sensitive and rapid approach for the determination of methylation via isothermal amplification coupled with quantum dot labeling, paving a new strategy for the early diagnosis and monitoring of cancer development.